Variability of Serial Lipoprotein-Associated Phospholipase [A.Sub.2] Measurements in Post-Myocardial Infarction Patients: Results from the AIRGENE Study Center Augsburg (Lipids, Lipoproteins, And Cardiovascular Risk Factors) (Clinical Report‪)‬

A systemic inflammatory response represents an important feature in atherothrombogenesis (1); therefore, measurement of plasma or serum concentrations of circulating inflammatory biomarkers could aid in identifying individuals at high risk for coronary heart disease (CHD). [4] A number of prospective studies of initially healthy individuals and patients with manifest atherosclerosis have convincingly demonstrated strong and independent associations between even slightly increased concentrations of various systemic markers of inflammation and a number of cardiovascular endpoints (2).